Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice

Keyphrases

• Renal Effects 100%
• SRAGE 100%
• Diabetic Mice 100%
• Db Mouse 85%
• Type 2 Diabetes Mellitus (T2DM) 28%
• Non-diabetic 28%
• Urinary Albumin Excretion 28%
• Advanced Glycation End Products 28%
• Creatinine Clearance 28%
• Mesangium 28%
• Renal Changes 28%
• Kidney Weight 28%
• Glomerular Volume 28%
• Basement Membrane Thickness 28%
• Placebo 14%
• Blood Glucose 14%
• Specific Receptor 14%
• Glucose-insulin System 14%
• Receptor-mediated 14%
• Insulin Level 14%
• One-group 14%
• Pathogenetic Factors 14%
• Diabetic Kidney Disease 14%
• Receptor for Advanced Glycation End Products 14%
• Food Consumption 14%
• Obese Type 2 Diabetes 14%

Medicine and Dentistry

• Maturity Onset Diabetes of the Young 100%
• Urinary System 66%
• Basement Membrane 66%
• Advanced Glycation End-Product 66%
• Creatinine Clearance 66%
• Placebo 33%
• Receptor 33%
• Body Weight 33%
• Diabetic Nephropathy 33%
• Food Intake 33%
• Blood Glucose 33%
• Advanced Glycation End Product Receptor 33%

Immunology and Microbiology

• Mouse 100%
• Db/Db Mouse 100%
• Glycation 60%
• Basement Membrane 40%
• Creatinine Clearance 40%
• Kidney Mass 40%
• Glucose Blood Level 20%
• Body Weight 20%
• Insulin Level 20%
• Isotype 20%